AURINIA PHARMACEUTICALS INC's ticker is AUPH and the CUSIP is 05156V102. A total of 168 filers reported holding AURINIA PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 1.25 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $38,880 | -71.3% | 9,000 | -50.0% | 0.01% | -33.3% |
| Q3 2022 | $135,680 | +50.8% | 18,000 | +100.0% | 0.01% | -18.2% |
| Q2 2022 | $90,000 | -95.8% | 9,000 | -94.8% | 0.01% | -81.7% |
| Q1 2022 | $2,127,000 | -63.6% | 171,800 | -32.7% | 0.06% | -49.6% |
| Q4 2021 | $5,839,000 | +24.7% | 255,300 | +20.7% | 0.12% | -16.8% |
| Q3 2021 | $4,683,000 | +353.8% | 211,600 | +165.8% | 0.14% | +286.5% |
| Q2 2021 | $1,032,000 | -79.9% | 79,600 | -79.9% | 0.04% | -71.3% |
| Q1 2021 | $5,142,000 | -50.1% | 396,000 | -46.9% | 0.13% | -34.2% |
| Q4 2020 | $10,311,000 | +115.4% | 745,500 | +129.4% | 0.20% | +10.1% |
| Q3 2020 | $4,788,000 | +209.7% | 325,000 | +241.7% | 0.18% | +67.9% |
| Q2 2020 | $1,546,000 | – | 95,100 | – | 0.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blackcrane Capital, LLC | 503,248 | $6,535,000 | 10.30% |
| Prosight Management, LP | 360,834 | $4,685,000 | 3.84% |
| Healthcare Value Capital, LLC | 100,000 | $1,299,000 | 2.89% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,748,208 | $22,700,000 | 2.32% |
| DG Capital Management, LLC | 591,154 | $7,676,000 | 1.83% |
| NEA Management Company, LLC | 5,172,683 | $67,193,000 | 1.51% |
| Altium Capital Management LP | 408,908 | $5,310,000 | 1.47% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 170,316 | $2,212,000 | 1.17% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 298,500 | $3,875,000 | 1.02% |
| KNOTT DAVID M | 154,840 | $2,011,000 | 0.86% |